Pt-rotaxanes as cytotoxic agents

Bioorganic and Medicinal Chemistry Letters

Volumn 21, Issue 22, 2011, Pages 6880-6883

  Wang, Xiaoyang ^a   Smithrud, David B ^a  

^a UNIVERSITY OF CINCINNATI   (United States)

Author keywords

Pt drugs; Rotaxanes; Transporters

Indexed keywords

1,2 PHENYLENEDIAMINE; ARGININE; CISPLATIN; CYTOTOXIC AGENT; DNA; LIPOCORTIN 5; PLATINUM; ROTAXANE;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CELL MEMBRANE; CONTROLLED STUDY; DNA MODIFICATION; DRUG CYTOTOXICITY; DRUG DNA BINDING; DRUG DNA INTERACTION; DRUG EFFECT; DRUG MECHANISM; DRUG SPECIFICITY; FEMALE; HUMAN; HUMAN CELL; OVARY CANCER;

ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL LINE, TUMOR; CYTOTOXINS; FEMALE; HUMANS; ORGANOPLATINUM COMPOUNDS; OVARIAN NEOPLASMS; ROTAXANES;

EID: 80054718000     PISSN: 0960894X     EISSN: 14643405     Source Type: Journal    
DOI: 10.1016/j.bmcl.2011.09.007     Document Type: Article

References (26)

1. L. Kelland Nat. Rev. Cancer 7 2007 573
2. E.R. Jamieson, and S.J. Lippard Chem. Rev. 99 1999 2467
3. W. Qiao, B. Wang, Y. Wang, L. Yang, Y. Zhang, and P. Shao J. Nanomater. 2010 Article ID: 796303
4. E. Gabano, M. Ravera, and D. Osella Curr. Med. Chem. 16 2009 4544
5. N. Wiradharma, Y. Zhang, S. Venkataraman, J.L. Hedrick, and Y.Y. Yang Nano Today 4 2009 302
6. P. Gramatica, E. Papa, M. Luini, E. Monti, M.B. Gariboldi, M. Ravera, E. Gabano, L. Gaviglio, and D. Osella J. Biol. Inorg. Chem. 15 2010 1157
7. J. Hamberger, M. Liebeke, M. Kaiser, K. Bracht, U. Olszewski, R. Zeillinger, G. Hamilton, D. Braun, and P.J. Bednarski Anticancer Drugs 20 2009 559
8. H. Choy, C. Park, and M. Yao Clin. Cancer Res. 14 2008 1633
9. B.L. Stocker, and J.O. Hoberg Organometallics 25 2006 4537
10. E. Gabano, M. Ravera, C. Cassino, S. Bonetti, G. Palmisano, and D. Osella Inorg. Chim. Acta 361 2008 1447
11. J. Provencher-Mandeville, C. Debnath, S.K. Mandal, V. Leblanc, S. Parent, E. Asselin, and G. Berube Steroids 76 2011 94
12. M. Huxley, C. Sanchez-Cano, M.J. Browning, C. Navarro-Ranninger, A.G. Quiroga, A. Rodger, and M.J. Hannon Dalton Trans. 39 2010 11353
13. A. Gupta, P. Saha, C. Descoteaux, V. Leblanc, E. Asselin, and G. Berube Bioorg. Med. Chem. Lett. 20 2010 1614
14. C. Sanchez-Cano, and M.J. Hannon Dalton Trans. 2009 10765
15. V. Gagnon, M.E. St-Germain, C. Descoteaux, J. Provencher-Mandeville, S. Parent, S.K. Mandal, E. Asselin, and G. Berube Bioorg. Med. Chem. Lett. 14 2004 5919
16. J. Moeker, and J. Thiem Eur. J. Org. Chem. 2009 4842
17. D.L. Ma, T.Y.T. Shum, F.Y. Zhang, C.M. Che, and M.S. Yang Chem. Commun. 2005 4675
18. D.P. Nowotnik, and E. Cvitkovic Adv. Drug Delivery Rev. 61 2009 1214
19. T. Dragovich, D. Mendelson, S. Kurtin, K. Richardson, D. Von Hoff, and A. Hoos Cancer Chemother. Pharmacol. 58 2006 759
20. G.P. Stathopoulos Anticancer Drugs 21 2010 732
21. J.-P. Sauvage, and C.O. Dietrich-Buchecker Molecular catenanes, rotaxanes and knots: a journey through the world of molecular topology 1999 Wiley-VCH Weinheim, Germany
22. I. Smukste, B.E. House, and D.B. Smithrud J. Org. Chem. 68 2003 2559
23. X. Wang, X. Bao, M. McFarland-Mancini, I. Isaacsohn, A.F. Drew, and D.B. Smithrud J. Am. Chem. Soc. 129 2007 7284
24. J. Zhu, B.E. House, E. Fleck, I. Isaacsohn, A.F. Drew, and D.B. Smithrud Bioorg. Med. Chem. Lett. 17 2007 5058
25. M.J. Cleare, and J.D. Hoeschele Bioinorg. Chem. 2 1973 187
26. D.W. Zehnder, and D.B. Smithrud Org. Lett. 3 2001 2485